Hypha Labs Forecast | Price, Price Target & Analyst Assessment

Hypha Labs

OTCPK:FUNI

$ 0,02

$0,00 (0,00%)

0,02 $

$0,00 (0,00%)

End-of-day quote: 03/27/2026

Hypha Labs Stock Value

The current analyst recommendation for OTCPK:FUNI is: sf_Data Unavailable.

Hypha Labs Company Info

EPS Growth 5Y

0,00%

Market Cap

$0,00 B

Long-Term Debt

$0,00 B

Short Interest

0,03%

Quarterly earnings

05/15/2026 (E)

Dividend

$0,00

Dividend Yield

0,00%

Founded

2010

Industry

Health Care

Country

United States

ISIN Number

US2538252022

Website

http://hyphalabs.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Hypha Labs’s Price Target has risen from $0,00 to $0,02 - a 100,00% increase.

Top growth stocks in the health care sector (5Y.)

What does Hypha Labs do?

Hypha Labs, Inc. (Hypha Labs), through wholly owned subsidiary, Hypha Products Inc., engages in the research, development and commercialization of a bioreactor, the Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. On February 20, 2024, the company completed the sale of the net assets of the company’s wholly owned subsidiary, Digipath Labs, Inc. The company’s easy-to-use device, together with its rep...

On February 20, 2024, the company completed the sale of the net assets of the company’s wholly owned subsidiary, Digipath Labs, Inc.

The company’s easy-to-use device, together with its replacement cartridges, safely and effectively produces enriched mycelium of functional mushrooms, or Micropearls, in just eight days. These Micropearls contain active mushroom ingredients that offer a way to harness the medicinal properties of fungi in a concentrated easy to handle tasteless and odorless form. These Micropearls can be incorporated into various food and beverages without altering the flavor.

The company’s Hypha Micropearl bioreactor will be sold with replaceable cartridges which are delivered pre-sterilized to the home and ready to be inserted into the device. These cartridges are filled with powerful nutrient formulations which allow for the production of the Micropearls. The QR codes on the cartridges are scanned to the Hypha Lab app and inserted into the device and the Micropearls are produced and fully formed in eight days. After harvesting the Micropoearls with a strainer, they are ready to be incorporated into a variety of foods. The cartridges help to minimize the risk of mold or yeast contamination and help improve the success of the at home mushroom growth. The company’s bioreactor technology will disrupt traditional methods of mushroom production and bring lab-quality nutrient ingredients into the home with convenience and efficiency.

The company intends to continue the design, development and testing of the Hypha Micropearl bioreactor over the next twelve months. Initially, the company will produce a limited number of bioreactors at the company’s headquarters for testing purposes, both with mycologists and experts in the functional mushroom industry. Upon completion of the design and successful testing of the Hypha Micropearl bioreactor, the company will seek to enter into a manufacturing arrangement outside the United States to manufacture the Hypha Micropearl bioreactor for commercial sale. The company’s intention is to be in the position to market the Micropearl bioreactor by the end of calendar year 2025, although there can be no assurance the company will achieve the company’s intention in this time period, or at all.

Intellectual Property

The company has filed two U.S. patent applications. The company uses the trademark Micropearls in connection with the company’s bioreactor device.

Government Regulation

As a manufacturer and distributor of consumer products in the United States, the company is subject to the Consumer Products Safety Act, which empowers the U.S. Consumer Products Safety Commission to exclude from the market products that are found to be unsafe or hazardous.

Marketing and Sales

The company intends to sell its products primarily online directly to consumers, with consumers purchasing the company’s Hypha Micropearl bioreactor directly through the company’s app. Customers will also be able to purchase replacement cartridges online through the company’s website or third- party providers. The company intends to offer a subscription service to the company’s users, where they can have regularly scheduled deliveries to their homes of replacement cartridges, which will offer savings compared to one-off purchases.

History

Hypha Labs, Inc. was founded in 2010. The company was incorporated in Nevada in 2010.

New support ticket

Explore

Hypha Labs Stock Value

Hypha Labs Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Hypha Labs do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Hypha Labs Stock Value

Hypha Labs Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Hypha Labs do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.